ATE376546T1 - Chinazolinonderivat - Google Patents
ChinazolinonderivatInfo
- Publication number
- ATE376546T1 ATE376546T1 AT02755797T AT02755797T ATE376546T1 AT E376546 T1 ATE376546 T1 AT E376546T1 AT 02755797 T AT02755797 T AT 02755797T AT 02755797 T AT02755797 T AT 02755797T AT E376546 T1 ATE376546 T1 AT E376546T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl group
- quinazolinone derivative
- onü
- äwherein
- pollakiuria
- Prior art date
Links
- AVRPFRMDMNDIDH-UHFFFAOYSA-N 1h-quinazolin-2-one Chemical class C1=CC=CC2=NC(O)=NC=C21 AVRPFRMDMNDIDH-UHFFFAOYSA-N 0.000 title abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 102000014415 Muscarinic acetylcholine receptor Human genes 0.000 abstract 1
- 108050003473 Muscarinic acetylcholine receptor Proteins 0.000 abstract 1
- 206010036018 Pollakiuria Diseases 0.000 abstract 1
- 206010046543 Urinary incontinence Diseases 0.000 abstract 1
- 230000008485 antagonism Effects 0.000 abstract 1
- 230000008602 contraction Effects 0.000 abstract 1
- 230000000994 depressogenic effect Effects 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000001020 rhythmical effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001241955 | 2001-08-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE376546T1 true ATE376546T1 (de) | 2007-11-15 |
Family
ID=19072309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02755797T ATE376546T1 (de) | 2001-08-09 | 2002-08-02 | Chinazolinonderivat |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7329665B2 (de) |
| EP (1) | EP1424334B1 (de) |
| JP (1) | JP4087337B2 (de) |
| KR (1) | KR100824506B1 (de) |
| CN (1) | CN1307172C (de) |
| AT (1) | ATE376546T1 (de) |
| CA (1) | CA2457351C (de) |
| DE (1) | DE60223151T2 (de) |
| DK (1) | DK1424334T3 (de) |
| ES (1) | ES2295382T3 (de) |
| PT (1) | PT1424334E (de) |
| TW (1) | TWI308567B (de) |
| WO (1) | WO2003016299A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8673353B2 (en) | 2008-02-11 | 2014-03-18 | Dainippon Sumitomo Pharma Co., Ltd | Tablet having improved elution properties |
| US20110262566A1 (en) * | 2008-11-07 | 2011-10-27 | Dainippon Sumitomo Pharma Co., Ltd. | Novel useful therapeutic agent for lower urinary tract symptom |
| KR20180011840A (ko) * | 2015-06-12 | 2018-02-02 | 비샬 자조디아 스와티 | 방광 출구 폐쇄 및/또는 하부 요로 증상의 치료에서 사용하기 위한 펜토산폴리설페이트나트륨을 포함하는 조성물 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE174908T1 (de) | 1993-05-26 | 1999-01-15 | Sumitomo Pharma | Chinazolinonderivate |
| US6645971B1 (en) * | 1998-10-16 | 2003-11-11 | Sumitomo Pharmaceuticals Company Limited | Quinazolinone derivatives |
-
2002
- 2002-08-02 CA CA002457351A patent/CA2457351C/en not_active Expired - Fee Related
- 2002-08-02 CN CNB028154843A patent/CN1307172C/zh not_active Expired - Fee Related
- 2002-08-02 JP JP2003521223A patent/JP4087337B2/ja not_active Expired - Fee Related
- 2002-08-02 PT PT02755797T patent/PT1424334E/pt unknown
- 2002-08-02 AT AT02755797T patent/ATE376546T1/de active
- 2002-08-02 KR KR1020047001829A patent/KR100824506B1/ko not_active Expired - Fee Related
- 2002-08-02 DK DK02755797T patent/DK1424334T3/da active
- 2002-08-02 EP EP02755797A patent/EP1424334B1/de not_active Expired - Lifetime
- 2002-08-02 US US10/485,865 patent/US7329665B2/en not_active Expired - Lifetime
- 2002-08-02 WO PCT/JP2002/007930 patent/WO2003016299A1/ja not_active Ceased
- 2002-08-02 DE DE60223151T patent/DE60223151T2/de not_active Expired - Lifetime
- 2002-08-02 ES ES02755797T patent/ES2295382T3/es not_active Expired - Lifetime
- 2002-08-09 TW TW091118017A patent/TWI308567B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1424334A1 (de) | 2004-06-02 |
| CA2457351C (en) | 2010-01-12 |
| DE60223151D1 (de) | 2007-12-06 |
| EP1424334A4 (de) | 2005-05-04 |
| CN1307172C (zh) | 2007-03-28 |
| DE60223151T2 (de) | 2008-08-07 |
| JP4087337B2 (ja) | 2008-05-21 |
| ES2295382T3 (es) | 2008-04-16 |
| TWI308567B (de) | 2009-04-11 |
| PT1424334E (pt) | 2008-01-10 |
| EP1424334B1 (de) | 2007-10-24 |
| WO2003016299A1 (en) | 2003-02-27 |
| KR20040020081A (ko) | 2004-03-06 |
| US20050032819A1 (en) | 2005-02-10 |
| US7329665B2 (en) | 2008-02-12 |
| CN1538966A (zh) | 2004-10-20 |
| CA2457351A1 (en) | 2003-02-27 |
| JPWO2003016299A1 (ja) | 2004-12-02 |
| DK1424334T3 (da) | 2008-02-11 |
| KR100824506B1 (ko) | 2008-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE472535T1 (de) | Pyrimidinmatrixmetalloproteinaseinhibitoren | |
| EP1437344A4 (de) | Benzolderivate, verfahren zu deren herstellung und deren verwendung | |
| DK1104760T3 (da) | Sulfamoylheteroarylpyrazolforbindelser som anti-inflammatoriske/analgetiske midler | |
| TW200510441A (en) | Novel compounds | |
| ATE377004T1 (de) | Proteinkinaseinhibitoren | |
| DE60331187D1 (de) | Kinaseinhibitoren | |
| HRP20080666T3 (en) | Cgrp receptor antagonists | |
| ATE339409T1 (de) | Trizyklische verbindungen | |
| EP1535922A4 (de) | Pyrrolopyridinderivat und dessen verwendung | |
| NO20071319L (no) | Fremgangsmate for fremstilling av isotiazolderivater. | |
| EP1364950A4 (de) | Pyridopyrimidin- und naphthyridinderivate | |
| EP1357124A4 (de) | Heterocyclische verbindungen und mittel, die die hirnfunktion verbessern und als wirkstoff diese verbindungen enthalten | |
| DK1031556T3 (da) | 2-phenoxyanilinderivater | |
| ATE376546T1 (de) | Chinazolinonderivat | |
| CA2366205A1 (en) | Biphenyl derivatives | |
| PT1122253E (pt) | Derivados de quinazolinona | |
| DK0612314T3 (da) | 2-pyrazinylethylaminderivater og deres anvendelse som lægemidler | |
| EP1364945A4 (de) | Benzimidazolidinonderivate | |
| UY26416A1 (es) | Compuestos | |
| WO2002080918A1 (en) | Remedial or prophylactic agent for frequent urination or urinary incontinence | |
| DK1049672T3 (da) | Azetidincarboxamid-derivater til behandling af CNS-lidelser | |
| NO20020475L (no) | 2-aminotetralinderivater for terapi av glaukom | |
| DK1282625T3 (da) | Anvendelsen af benzoxaziner i behandlingen af Parkinsons sygdom | |
| DK1049670T3 (da) | Azetidincarboxamidderivater til behandling af CNS-lidelser | |
| EP1650199A4 (de) | Sulfonamidderivat mit isoxazolring |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1424334 Country of ref document: EP |